top of page
Open Site Navigation

Our work revolves around providing hope for patients.

About Us

Our mission is to transform cancer patients
into cancer survivors

Investors

We are moving forward confidently to realize our mission and create value

We are committed to providing hope in the face of despair by developing a tumor-targeting drug (SONALA-001) together with MR-guided focused ultrasound as sonodynamic therapy (SDT). This combination has the potential to be a safe and effective noninvasive treatment for cancer.

SonALAsense is the first company to advance SDT into clinical trials.

Soundly Defeating Cancer

Soundly

Defeating

Cancer

Our mission is to create

cancer survivors

SDT is a Platform Technology

SonALAsense is pursuing a Pipeline of additional indications utilizing SDT to treat multiple tumor types.

Investors

We are moving forward confidently to realize our mission and create value

About Us

Our mission is to transform cancer patients into cancer survivors

Our science targets cancer's own needs to cause it to destroy itself.

SDT metabolically targets cancer cells causing immediate and programmed cell death.

Clinical trials now recruiting, Contact Us to learn more about eligibility.

bottom of page